Great advances were made in the pharmacologic-based treatment of cancer in prior decades. However, despite a marked increase in our understanding ofcell and molecular mechanisms underlying the neoplastic process, therapy for advanced disease remains limited. While the reasons for this are many, it is generally accepted that advanced neoplasms contain a relatively large number of genetic and molecularalterations contributingto the maintenanceofthe neoplastic process. Such a situation precludes easy pharmacologic intervention ...

Cancer Chemoprevention 2012, Springer

ISBN-13: 9781461356639

Softcover Reprint of the Origi edition

Trade paperback

Select
Cancer Chemoprevention 2001, Springer, Boston, MA

ISBN-13: 9780792372592

2001 edition

Hardcover

Select